Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thalidomide for treatment of beta-thalassemia in children
ChiCTR2000034998Phase 4Not yet recruiting
- Sponsor
- Sun Yat-sen Memorial Hospital
- Start
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of thalidomide in beta thalassemia, sponsored by Sun Yat-sen Memorial Hospital. Primary endpoint: Hemoglobin. Planned start Aug 2020; status: not yet recruiting.
02
Drugs
thalidomide
03
Conditions
beta thalassemia
Beyond the preview
Go deeper on ChiCTR2000034998.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000034998.